chr13-110512608-C-G

Position:

• chr13-110512608-C-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BA1

The NM_001846.4(COL4A2):​c.*417C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.883 in 180,346 control chromosomes in the GnomAD database, including 70,520 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.88 (58859 hom., cov: 33)
  • Exomes 𝑓: 0.91 (11661 hom.)
• Consequence: COL4A2 NM_001846.4 3_prime_UTR
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:2
• Conservation: PhyloP100: -4.07

Genes affected

COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]

ACMG classification

Verdict is Benign. Variant got -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.93).
• BP6: Variant 13-110512608-C-G is Benign according to our data. Variant chr13-110512608-C-G is described in ClinVar as [Benign]. Clinvar id is 311205.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BA1: GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.93 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
COL4A2	NM_001846.4	c.*417C>G		3_prime_UTR_variant	48/48	ENST00000360467.7	NP_001837.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
COL4A2	ENST00000360467.7	c.*417C>G		3_prime_UTR_variant	48/48	5	NM_001846.4	ENSP00000353654	P1
COL4A2	ENST00000648222.1	n.1244C>G		non_coding_transcript_exon_variant	1/1
COL4A2	ENST00000650225.1	n.3211C>G		non_coding_transcript_exon_variant	19/19

Frequencies

GnomAD3 genomes AF: 0.878 AC: 133482 AN: 152116 Hom.: 58820 Cov.: 33

Gnomad AFR AF: 0.783

Gnomad AMI AF: 0.988

Gnomad AMR AF: 0.888

Gnomad ASJ AF: 0.831

Gnomad EAS AF: 0.946

Gnomad SAS AF: 0.953

Gnomad FIN AF: 0.954

Gnomad MID AF: 0.848

Gnomad NFE AF: 0.912

Gnomad OTH AF: 0.860

GnomAD4 exome AF: 0.910 AC: 25587 AN: 28112 Hom.: 11661 Cov.: 0 AF XY: 0.913 AC XY: 13064 AN XY: 14314

Gnomad4 AFR exome AF: 0.785

Gnomad4 AMR exome AF: 0.896

Gnomad4 ASJ exome AF: 0.832

Gnomad4 EAS exome AF: 0.933

Gnomad4 SAS exome AF: 0.935

Gnomad4 FIN exome AF: 0.947

Gnomad4 NFE exome AF: 0.913

Gnomad4 OTH exome AF: 0.895

GnomAD4 genome AF: 0.877 AC: 133581 AN: 152234 Hom.: 58859 Cov.: 33 AF XY: 0.883 AC XY: 65695 AN XY: 74438

Gnomad4 AFR AF: 0.783

Gnomad4 AMR AF: 0.889

Gnomad4 ASJ AF: 0.831

Gnomad4 EAS AF: 0.947

Gnomad4 SAS AF: 0.953

Gnomad4 FIN AF: 0.954

Gnomad4 NFE AF: 0.912

Gnomad4 OTH AF: 0.861

Alfa AF: 0.894 Hom.: 2972

Bravo AF: 0.867

ClinVar

Significance: Benign

Submissions summary: Benign:2

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Porencephaly 2 Benign:1

Benign, criteria provided, single submitter

clinical testing

Illumina Laboratory Services, Illumina

Jan 12, 2018

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1

Benign, criteria provided, single submitter

not provided

Breakthrough Genomics, Breakthrough Genomics

-

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.93
CADD	Benign	0.40
DANN	Benign	0.48

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs10509; hg19: chr13-111164955;